Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Baxter
Express Scripts
AstraZeneca
Moodys

Last Updated: April 10, 2020

DrugPatentWatch Database Preview

BENZTROPINE MESYLATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Benztropine Mesylate, and when can generic versions of Benztropine Mesylate launch?

Benztropine Mesylate is a drug marketed by Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Navinta Llc, Aspen Global Inc, Chartwell Rx, Epic Pharma Llc, Invagen Pharms, Lannett Co Inc, Leading Pharma Llc, Oxford Pharms, Pliva, Quantum Pharmics, Upsher Smith Labs, Usl Pharma, and Vintage. and is included in twenty-six NDAs.

The generic ingredient in BENZTROPINE MESYLATE is benztropine mesylate. There are seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.

US ANDA Litigation and Generic Entry Outlook for Benztropine Mesylate

A generic version of BENZTROPINE MESYLATE was approved as benztropine mesylate by PLIVA on August 10th, 1988.

  Start Trial

Drug patent expirations by year for BENZTROPINE MESYLATE
Drug Prices for BENZTROPINE MESYLATE

See drug prices for BENZTROPINE MESYLATE

Drug Sales Revenue Trends for BENZTROPINE MESYLATE

See drug sales revenues for BENZTROPINE MESYLATE

Recent Clinical Trials for BENZTROPINE MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Boehringer IngelheimPhase 2
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2

See all BENZTROPINE MESYLATE clinical trials

Pharmacology for BENZTROPINE MESYLATE
Medical Subject Heading (MeSH) Categories for BENZTROPINE MESYLATE
Synonyms for BENZTROPINE MESYLATE
(1R,3r,5S)-3-(benzhydryloxy)-8-methyl-8-azabicyclo[3.2.1]octane methanesulfonate
(1r,5r)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane methanesulfonate(1:1)
(1R,5S)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonic acid
1-alpha-H,5-alpha-H-Tropane, 3-alpha-(diphenylmethoxy)-, methanesulfonate
1.alpha.H, 3.alpha.-(diphenylmethoxy)-, methanesulfonate
102701-02-0
132-17-2
132B172
1alphaH,5alphaH-Tropane, 3alpha-(diphenylmethoxy)-, methanesulfonate
1alphaH,5alphaH-Tropane, 3alpha-(diphenylmethoxy)-, methanesulfonate (8CI)
3-(Benzhydryloxy)-8-methyl-8-azabicyclo[3.2.1]octane methanesulfonate
3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane, methanesulfonic acid
3-alpha-(Diphenylmethoxy)-1-alpha-H, 5-alpha-H-tropane methanesulfonate
3-Diphenyl methoxytropane methanesulfonate
3-Diphenylmethoxytropane mesylate
3-Diphenylmethoxytropane methanesulfonate
3a-(Diphenylmethoxy)-1a H,5a H-tropane methanesulfonate
3alpha-(Diphenylmethoxy)-1alphaH,5alphaH-tropane methanesulfonate
8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-, methanesulfonate
8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-, methanesulfonate (9CI)
8-Azabicyclo[3.2.1]octane, endo-, methanesulfonate
AB0021001
ACN-051261
AK122005
AKOS008105137
AKOS025214111
AKOS026750089
AOB5795
API0001645
AS-17846
AX8001513
B 8262
Benzatropine mesilate
benzatropine mesylate
Benzatropine methanesulfonate
benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether methanesulfonate
Benzophenone-3,3'-4,4'-tetracarboxylic dianhydrie
Benzotropine mesylate
Benzotropine methanesulfonate
Benzotropinemesylate
Benztropine (mesylate)
Benztropine mesilate
Benztropine mesilate (JAN)
Benztropine mesylate (USP)
Benztropine mesylate [USP]
Benztropine mesylate, >=98% (HPLC)
Benztropine mesylate, United States Pharmacopeia (USP) Reference Standard
Benztropine methanesulfonate
Benztropine methylsulfonate
benztropine-mesylate
benztropinemesylate
C21H25NO.CH4O3S
CAS-132-17-2
CCG-221176
CCG-221498
CCG-37380
CHEBI:3049
CHEMBL1200383
CHEMBL1257125
CHEMBL1442985
CHEMBL85236
Cobrentin methanesulfonate
Cogentin
Cogentin (TN)
Cogentin mesylate
Cogentin methanesulfonate
CPD000394012
CS-2733
CTK4B7776
CTK7B4522
D00778
DSSTox_CID_25096
DSSTox_GSID_45096
DSSTox_RID_80668
DTXSID0045096
EBD49028
EINECS 205-048-8
EN300-51031
endo-3-(Diphenylmethoxy)-8-methyl-8-azoniabicyclo(3.2.1)octane methanesulphonate
EU-0100194
HMS2747A15
HMS3259P11
HMS3260H09
HMS3652K07
HMS3715L13
HY-B0520A
KS-00000XL0
Lopac-B-8262
LP00194
LS-157781
MCULE-4736181346
MK 02
MLS000737056
N-methylbenztropine
NC00646
NCGC00013495
NCGC00013495-01
NCGC00013495-02
NCGC00016118-01
NCGC00016118-02
NCGC00093670-01
NCGC00096609-01
NCGC00260879-01
NCI42199
NSC 169913
NSC-169913
NSC-42199
NSC169913
NSC42199
Opera_ID_1229
Q-200693
Q27105931
s3163
SAM002548938
SB19689
SC-20236
SCHEMBL1648656
SCHEMBL41808
SCHEMBL41809
SMR000394012
SR-01000075303
SR-01000075303-1
SR-01000075303-5
ST24041528
ST50997629
SW219521-1
Tox21_110028
Tox21_500194
Tropine benzohydryl ether methanesulfonate
UNII-WMJ8TL7510
V2115
WLN: T56 A ANTJ A1 GOYR & R & OSW1
WMJ8TL7510

US Patents and Regulatory Information for BENZTROPINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 040103-002 Dec 12, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Quantum Pharmics BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 088514-001 Jan 31, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 040103-003 Dec 12, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Quantum Pharmics BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 088510-001 Jan 31, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa BENZTROPINE MESYLATE benztropine mesylate INJECTABLE;INJECTION 090233-001 Jul 28, 2009 AP RX No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 088895-001 Apr 11, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Oxford Pharms BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 040706-001 Feb 14, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Baxter
Express Scripts
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.